Quarterly Statement Of Cash Flows

HISAMITSU PHARMACEUTICAL CO.,INC. - Filing #7566829

Concept	As at 2023-02-28	2022-03-01 to 2023-02-28	As at 2022-02-28	2021-03-01 to 2022-02-28	As at 2021-02-28
Quarterly statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal	—	16,179,000,000 JPY	—	18,282,000,000 JPY	—
Interest and dividends received	—	1,897,000,000 JPY	—	1,446,000,000 JPY	—
Interest paid	—	-15,000,000 JPY	—	-20,000,000 JPY	—
Income taxes paid	—	-5,333,000,000 JPY	—	-505,000,000 JPY	—
Net cash provided by (used in) operating activities	—	12,727,000,000 JPY	—	19,199,000,000 JPY	—
Cash flows from investing activities
Purchase of property, plant and equipment	—	-7,859,000,000 JPY	—	-3,610,000,000 JPY	—
Proceeds from sale of property, plant and equipment	—	1,004,000,000 JPY	—	37,000,000 JPY	—
Purchase of investment securities	—	-5,897,000,000 JPY	—	-340,000,000 JPY	—
Proceeds from collection of loans receivable	—	2,000,000 JPY	—	2,000,000 JPY	—
Net cash provided by (used in) investing activities	—	-23,868,000,000 JPY	—	-13,060,000,000 JPY	—
Cash flows from financing activities
Repayments of long-term borrowings	—	-71,000,000 JPY	—	-77,000,000 JPY	—
Purchase of treasury shares	—	-7,694,000,000 JPY	—	-8,043,000,000 JPY	—
Dividends paid	—	-6,719,000,000 JPY	—	-6,839,000,000 JPY	—
Other, net	—	-140,000,000 JPY	—	-144,000,000 JPY	—
Net cash provided by (used in) financing activities	—	-14,687,000,000 JPY	—	-15,189,000,000 JPY	—
Effect of exchange rate change on cash and cash equivalents	—	5,005,000,000 JPY	—	3,944,000,000 JPY	—
Net increase (decrease) in cash and cash equivalents	—	-20,822,000,000 JPY	—	-5,106,000,000 JPY	—
Cash and cash equivalents	65,424,000,000 JPY	—	86,247,000,000 JPY	—	91,354,000,000 JPY